Results of a phase III clinical trial: CHOP versus CMED in peripheral T-cell lymphoma unspecified
✍ Scribed by Agustin Avilés; Claudia Castañeda; Natividad Neri; Sergio Cleto; Alejandra Talavera; Martha González; Judith Huerta-Guzmán; M. Jesús Nambo
- Book ID
- 107576678
- Publisher
- Springer US
- Year
- 2008
- Tongue
- English
- Weight
- 142 KB
- Volume
- 25
- Category
- Article
- ISSN
- 1357-0560
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND To assess the impact of T‐cell/B‐cell phenotype on clinical outcome, the authors retrospectively compared patients who had peripheral T‐cell lymphoma, unspecified (PTCL‐U), with patients who had diffuse large B‐cell lymphoma (DLBCL). ## METHODS Two hundred ninety‐seven
## BACKGROUND. The authors previously have found that in patients with locally advanced squamous cell carcinoma of the head and neck (SCC-HN), alternating chemoradiotherapy (ALT) was superior to low-total-dose conventional radiotherapy alone. The purpose of this randomized trial was to compare the